Overview of the Class Action Lawsuit
Levi & Korsinsky, LLP has recently taken action on behalf of shareholders of Skye Bioscience, Inc. This legal step aims to recover potential losses incurred by investors due to alleged misleading statements made by the company. The firm emphasizes the importance of empowering shareholders who may have faced financial setbacks linked to the company's performance.
Who is Affected?
This class action specifically includes investors who acquired shares of Skye Bioscience, Inc. The allegations center around purported securities fraud that took place between November 4, 2024, and October 3, 2025. If you fit this time frame and suffered losses, it may be worthwhile to consider your options regarding recovery.
Understanding the Allegations
The complaint filed by Levi & Korsinsky highlights critical issues regarding the company's lead product candidate, nimacimab. Investors were reportedly led to believe that nimacimab would be more effective and commercially viable than it turned out to be. This resulted in significantly overstated clinical and regulatory prospects, which are said to have misled investors regarding the true potential of the product.
What Are the Next Steps?
For those affected, it’s vital to act promptly. Investors have until January 16, 2026, to request the Court to appoint them as lead plaintiffs. It's crucial to note that participating does not require you to take on this role, and you can still potentially benefit from any recovery made.
No Cost to Participate
Levi & Korsinsky assures potential class members that they can participate without incurring any costs or fees upfront. This means that if you qualify as a class member, there could be compensation available without any financial risk on your part. This clear no-cost approach aims to provide peace of mind for investors who may feel overwhelmed by legal processes.
Why Choose Levi & Korsinsky?
The law firm has a substantial history of advocating for shareholders, with over two decades of experience in handling complex securities litigation. They have successfully secured hundreds of millions of dollars for investors and continue to be recognized as a leading firm in this field. With a dedicated team of over 70 professionals, their commitment to their clients remains strong.
Contact Information
For further assistance, interested parties can reach out to Levi & Korsinsky, LLP. Joseph E. Levi, Esq., along with Ed Korsinsky, Esq., are handling inquiries related to this class action. You can contact them directly at their office located at 33 Whitehall Street, 27th Floor, New York, NY 10004. The firm's phone number is (212) 363-7500 for direct communication. If you wish to learn more about the firm, visit their official website.
Frequently Asked Questions
What is the class action about?
The class action lawsuit filed by Levi & Korsinsky seeks to recover losses for investors of Skye Bioscience, Inc. due to alleged securities fraud.
What are the time limits to join the lawsuit?
You have until January 16, 2026, to request the Court appoint you as lead plaintiff if you suffered a loss during the relevant period.
Is there any cost associated with participating in the class action?
No, there are no costs or fees to participate. Class members can seek compensation without any out-of-pocket expenses.
How long has Levi & Korsinsky been in operation?
Levi & Korsinsky has over 20 years of experience in representing shareholders and managing complex securities cases.
Who should I contact for more information about the lawsuit?
You can reach out to Levi & Korsinsky at (212) 363-7500 or visit their website for more details regarding the class action.
